» Articles » PMID: 18848174

Prevalence of Drug-drug Interactions at Hospital Entry and During Hospital Stay of Patients in Internal Medicine

Overview
Specialty General Medicine
Date 2008 Oct 14
PMID 18848174
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to assess potential drug-drug interactions (pDDIs) at hospital admission, during hospitalization and at discharge and to evaluate the number of pDDIs created during hospitalization.

Methods: The medication of 851 patients was screened for pDDIs (major and moderate severity) using the screening program Pharmavista. The frequency of pDDIs per patient, per number of drugs and drug pairs was estimated.

Results: During hospitalization, the frequency of major and moderate pDDIs per patient was 1.11, which was higher compared to hospital admission (0.59) or to hospital discharge (0.60). The frequency of major and moderate pDDIs per drug prescribed (13.7% vs. 9.1%) or per drug pairs analyzed (4.5% vs. 2.3%) was higher at hospital admission compared to hospital discharge. 47% of all major and moderate pDDIs at discharge were due to a medication change during hospitalization.

Conclusions: Although the number of major and moderate pDDIs per patient did not increase from hospital admission to discharge, it is important to realize that 47% of all major and moderate DDIs at hospital discharge were created during hospitalization. Prescribing drugs with a low risk for pDDIs as well as careful monitoring for adverse drug reactions are important measures to minimize harm associated with DDIs.

Citing Articles

A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial.

Simal I, Somers A, Amrouch C, Capiau A, Cherubini A, Cruz-Jentoft A Eur Geriatr Med. 2024; 15(5):1357-1367.

PMID: 39095682 DOI: 10.1007/s41999-024-01025-7.


Expanding access to veterinary clinical decision support in resource-limited settings: a scoping review of clinical decision support tools in medicine and antimicrobial stewardship.

Yusuf H, Hillman A, Stegeman J, Cameron A, Badger S Front Vet Sci. 2024; 11:1349188.

PMID: 38895711 PMC: 11184142. DOI: 10.3389/fvets.2024.1349188.


The Prevalence and Severity of Potential Drug-Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital.

Hamadouk R, Alshareif E, Hamad H, Yousef B Drug Healthc Patient Saf. 2023; 15:149-157.

PMID: 37933264 PMC: 10625782. DOI: 10.2147/DHPS.S436458.


Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support.

Zhang T, Gephart S, Subbian V, Boyce R, Villa-Zapata L, Tan M Appl Clin Inform. 2023; 14(4):779-788.

PMID: 37793617 PMC: 10550365. DOI: 10.1055/s-0043-1772686.


The importance of graph databases and graph learning for clinical applications.

Walke D, Micheel D, Schallert K, Muth T, Broneske D, Saake G Database (Oxford). 2023; 2023.

PMID: 37428679 PMC: 10332447. DOI: 10.1093/database/baad045.